Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global and United States Clinical Mass Spectrometry Market Report & Forecast 2024-2030

Global and United States Clinical Mass Spectrometry Market Report & Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-10-09

Pages: 108 Pages

Report ld: 3337622

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics. Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.

The global Clinical Mass Spectrometry revenue was US$ 925 million in 2023 and is forecast to a readjusted size of US$ 1798 million by 2030 with a CAGR of 10.1% during the review period (2024-2030).

Clinical Mass Spectrometry Market Size

M= millions and B=billions

In United States the Clinical Mass Spectrometry revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Clinical Mass Spectrometry market, also covers the segmentation data of other regions in regional level and county level.

Clinical Mass Spectrometry Market Drivers:
Rising Demand for Personalized Medicine: The increasing focus on personalized medicine in diagnosing and treating diseases is driving the demand for clinical mass spectrometry. Its ability to accurately analyze biomarkers, metabolites, and proteins makes it a key tool in personalized healthcare.

Technological Advancements: Innovations in mass spectrometry, such as higher sensitivity, faster analysis, and miniaturization, have expanded its clinical applications, improving diagnostic accuracy and speeding up workflows in laboratories.

Growing Prevalence of Chronic Diseases: The rising incidence of chronic diseases like cancer, cardiovascular disorders, and metabolic conditions has increased the need for precise diagnostic tools, further propelling the adoption of mass spectrometry in clinical settings.

Expanding Use in Clinical Diagnostics: Mass spectrometry is being increasingly applied in clinical diagnostics, including newborn screening, therapeutic drug monitoring, and toxicology testing, due to its accuracy, sensitivity, and ability to detect low-abundance molecules.

Clinical Mass Spectrometry Market Challenges:
High Equipment and Operational Costs: Clinical mass spectrometers are expensive to purchase and maintain, limiting their adoption, especially in smaller laboratories or in low- and middle-income countries where budgets are constrained.

Requirement for Skilled Personnel: The operation and interpretation of mass spectrometry data require highly trained professionals. A shortage of skilled personnel in many regions can hinder the widespread use of this technology.

Complexity and Time-Intensive Nature of the Technique: While mass spectrometry provides highly accurate results, the complexity of sample preparation and the time required for analysis can be a limiting factor in high-throughput clinical settings.

Regulatory Barriers: The approval process for new mass spectrometry-based diagnostic tests can be slow due to stringent regulatory requirements, delaying the introduction of innovative solutions into the clinical market.

Global clinical mass spectrometry key players include Danaher, Bruker, Thermo Fisher, Agilent, Waters, etc. Global top 5 manufacturers hold a share about 80%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 34%.In terms of product, LC-MS is the largest segment, with a share over 75%. And in terms of application, the largest application is clinical diagnostics, followed by clinical research.

Clinical Mass Spectrometry market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Clinical Mass Spectrometry market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Clinical Mass Spectrometry market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

Market Segmentation

Report Metric
Details
Report Title
Global and United States Clinical Mass Spectrometry Market Report & Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1798 million
CAGR(2024-2030)
10.1%
Market Size Available for Years
2019-2030
Global Clinical Mass Spectrometry Companies Covered
Danaher, Bruker, Agilent, Thermo Fisher, Waters, Shidmazu, Perkin Elmer
Global Clinical Mass Spectrometry Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Mass Spectrometry Market, Segment by Type
LC-MS

MALDI-TOF MS

Other
Global Clinical Mass Spectrometry Market, Segment by Application
Clinical Diagnostics

Clinical Research
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces Clinical Mass Spectrometry definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Clinical Mass Spectrometry companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Clinical Mass Spectrometry in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Mass Spectrometry sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion

 1 Study Coverage
    1.1 Clinical Mass Spectrometry Product Introduction
    1.2 Global Clinical Mass Spectrometry Outlook 2019 VS 2023 VS 2030
        1.2.1 Global Clinical Mass Spectrometry Sales in US$ Million for the Year 2019-2030
        1.2.2 Global Clinical Mass Spectrometry Sales in Volume for the Year 2019-2030
    1.3 United States Clinical Mass Spectrometry Outlook 2019 VS 2023 VS 2030
        1.3.1 United States Clinical Mass Spectrometry Sales in US$ Million for the Year 2019-2030
        1.3.2 United States Clinical Mass Spectrometry Sales in Volume for the Year 2019-2030
    1.4 Clinical Mass Spectrometry Market Size, United States VS Global, 2019 VS 2023 VS 2030
        1.4.1 The Market Share of United States Clinical Mass Spectrometry in Global, 2019 VS 2023 VS 2030
        1.4.2 The Growth Rate of Clinical Mass Spectrometry Market Size, United States VS Global, 2019 VS 2023 VS 2030
    1.5 Clinical Mass Spectrometry Market Dynamics
        1.5.1 Clinical Mass Spectrometry Industry Trends
        1.5.2 Clinical Mass Spectrometry Market Drivers
        1.5.3 Clinical Mass Spectrometry Market Challenges
        1.5.4 Clinical Mass Spectrometry Market Restraints
    1.6 Assumptions and Limitations
    1.7 Study Objectives
    1.8 Years Considered

 2 Clinical Mass Spectrometry by Type
    2.1 Clinical Mass Spectrometry Market by Type
        2.1.1 LC-MS
        2.1.2 MALDI-TOF MS
        2.1.3 Other
    2.2 Global Clinical Mass Spectrometry Market Size by Type
        2.2.1 Global Clinical Mass Spectrometry Sales in Value, by Type (2019, 2023 & 2030)
        2.2.2 Global Clinical Mass Spectrometry Sales in Volume, by Type (2019, 2023 & 2030)
        2.2.3 Global Clinical Mass Spectrometry Average Selling Price (ASP) by Type (2019, 2023 & 2030)
    2.3 United States Clinical Mass Spectrometry Market Size by Type
        2.3.1 United States Clinical Mass Spectrometry Sales in Value, by Type (2019, 2023 & 2030)
        2.3.2 United States Clinical Mass Spectrometry Sales in Volume, by Type (2019, 2023 & 2030)
        2.3.3 United States Clinical Mass Spectrometry Average Selling Price (ASP) by Type (2019, 2023 & 2030)

 3 Clinical Mass Spectrometry by Application
    3.1 Clinical Mass Spectrometry Market by Application
        3.1.1 Clinical Diagnostics
        3.1.2 Clinical Research
    3.2 Global Clinical Mass Spectrometry Market Size by Application
        3.2.1 Global Clinical Mass Spectrometry Sales in Value, by Application (2019, 2023 & 2030)
        3.2.2 Global Clinical Mass Spectrometry Sales in Volume, by Application (2019, 2023 & 2030)
        3.2.3 Global Clinical Mass Spectrometry Average Selling Price (ASP) by Application (2019, 2023 & 2030)
    3.3 United States Clinical Mass Spectrometry Market Size by Application
        3.3.1 United States Clinical Mass Spectrometry Sales in Value, by Application (2019, 2023 & 2030)
        3.3.2 United States Clinical Mass Spectrometry Sales in Volume, by Application (2019, 2023 & 2030)
        3.3.3 United States Clinical Mass Spectrometry Average Selling Price (ASP) by Application (2019, 2023 & 2030)

 4 Global Clinical Mass Spectrometry Competitor Landscape by Company
    4.1 Global Clinical Mass Spectrometry Market Size by Company
        4.1.1 Global Key Manufacturers of Clinical Mass Spectrometry, Ranked by Revenue (2023)
        4.1.2 Global Clinical Mass Spectrometry Revenue by Manufacturer (2019-2024)
        4.1.3 Global Clinical Mass Spectrometry Sales by Manufacturer (2019-2024)
        4.1.4 Global Clinical Mass Spectrometry Price by Manufacturer (2019-2024)
    4.2 Global Clinical Mass Spectrometry Concentration Ratio (CR)
        4.2.1 Clinical Mass Spectrometry Market Concentration Ratio (CR) (2019-2024)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Clinical Mass Spectrometry in 2023
        4.2.3 Global Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Key Manufacturers of Clinical Mass Spectrometry, Manufacturing Base Distribution and Headquarters
    4.4 Global Key Manufacturers of Clinical Mass Spectrometry, Product Offered and Application
    4.5 Global Key Manufacturers of Clinical Mass Spectrometry, Date of Enter into This Industry
    4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.7 United States Clinical Mass Spectrometry Market Size by Company
        4.7.1 Key Players of Clinical Mass Spectrometry in United States, Ranked by Revenue (2023)
        4.7.2 United States Clinical Mass Spectrometry Revenue by Players (2019-2024)
        4.7.3 United States Clinical Mass Spectrometry Sales by Players (2019-2024)

 5 Global Clinical Mass Spectrometry Market Size by Region
    5.1 Global Clinical Mass Spectrometry Market Size by Region: 2019 VS 2023 VS 2030
    5.2 Global Clinical Mass Spectrometry Market Size in Volume by Region (2019-2030)
        5.2.1 Global Clinical Mass Spectrometry Sales in Volume by Region: 2019-2024
        5.2.2 Global Clinical Mass Spectrometry Sales in Volume Forecast by Region (2025-2030)
    5.3 Global Clinical Mass Spectrometry Market Size in Value by Region (2019-2030)
        5.3.1 Global Clinical Mass Spectrometry Sales in Value by Region: 2019-2024
        5.3.2 Global Clinical Mass Spectrometry Sales in Value by Region: 2025-2030

 6 Americas
    6.1 Americas Clinical Mass Spectrometry Market Size YoY Growth 2019-2030
    6.2 Americas Clinical Mass Spectrometry Sales in Volume, by Type (2019, 2023 & 2030)
    6.3 Americas Clinical Mass Spectrometry Sales in Volume, by Application (2019, 2023 & 2030)
    6.4 Americas Clinical Mass Spectrometry Market Facts & Figures by Country (2019, 2023 & 2030)
        6.4.1 Americas Clinical Mass Spectrometry Sales in Value by Country (2019, 2023 & 2030)
        6.4.2 Americas Clinical Mass Spectrometry Sales in Volume by Country (2019, 2023 & 2030)
        6.4.3 United States
        6.4.4 Canada
        6.4.5 Mexico
        6.4.6 Brazil

 7 EMEA
    7.1 EMEA Clinical Mass Spectrometry Market Size YoY Growth 2019-2030
    7.2 EMEA Clinical Mass Spectrometry Sales in Volume, by Type (2019, 2023 & 2030)
    7.3 EMEA Clinical Mass Spectrometry Sales in Volume, by Application (2019, 2023 & 2030)
    7.4 EMEA Clinical Mass Spectrometry Market Facts & Figures by Country (2019, 2023 & 2030)
        7.4.1 EMEA Clinical Mass Spectrometry Sales in Value by Country (2019, 2023 & 2030)
        7.4.2 EMEA Clinical Mass Spectrometry Sales in Volume by Country (2019, 2023 & 2030)
        7.4.3 Europe
        7.4.4 Middle East
        7.4.5 Africa

 8 China
    8.1 China Clinical Mass Spectrometry Market Size YoY Growth 2019-2030
    8.2 China Clinical Mass Spectrometry Sales in Volume, by Type (2019, 2023 & 2030)
    8.3 China Clinical Mass Spectrometry Sales in Volume, by Application (2019, 2023 & 2030)

 9 APAC
    9.1 APAC Clinical Mass Spectrometry Market Size YoY Growth 2019-2030
    9.2 APAC Clinical Mass Spectrometry Sales in Volume, by Type (2019, 2023 & 2030)
    9.3 APAC Clinical Mass Spectrometry Sales in Volume, by Application (2019, 2023 & 2030)
    9.4 APAC Clinical Mass Spectrometry Market Facts & Figures by Country (2019, 2023 & 2030)
        9.4.1 APAC Clinical Mass Spectrometry Sales in Value by Country (2019, 2023 & 2030)
        9.4.2 APAC Clinical Mass Spectrometry Sales in Volume by Country (2019, 2023 & 2030)
        9.4.3 Japan
        9.4.4 South Korea
        9.4.5 China Taiwan
        9.4.6 Southeast Asia
        9.4.7 India

 10 Company Profiles
    10.1 Danaher
        10.1.1 Danaher Company Information
        10.1.2 Danaher Description and Business Overview
        10.1.3 Danaher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
        10.1.4 Danaher Clinical Mass Spectrometry Products Offered
        10.1.5 Danaher Recent Development
    10.2 Bruker
        10.2.1 Bruker Company Information
        10.2.2 Bruker Description and Business Overview
        10.2.3 Bruker Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
        10.2.4 Bruker Clinical Mass Spectrometry Products Offered
        10.2.5 Bruker Recent Development
    10.3 Agilent
        10.3.1 Agilent Company Information
        10.3.2 Agilent Description and Business Overview
        10.3.3 Agilent Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
        10.3.4 Agilent Clinical Mass Spectrometry Products Offered
        10.3.5 Agilent Recent Development
    10.4 Thermo Fisher
        10.4.1 Thermo Fisher Company Information
        10.4.2 Thermo Fisher Description and Business Overview
        10.4.3 Thermo Fisher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
        10.4.4 Thermo Fisher Clinical Mass Spectrometry Products Offered
        10.4.5 Thermo Fisher Recent Development
    10.5 Waters
        10.5.1 Waters Company Information
        10.5.2 Waters Description and Business Overview
        10.5.3 Waters Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
        10.5.4 Waters Clinical Mass Spectrometry Products Offered
        10.5.5 Waters Recent Development
    10.6 Shidmazu
        10.6.1 Shidmazu Company Information
        10.6.2 Shidmazu Description and Business Overview
        10.6.3 Shidmazu Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
        10.6.4 Shidmazu Clinical Mass Spectrometry Products Offered
        10.6.5 Shidmazu Recent Development
    10.7 Perkin Elmer
        10.7.1 Perkin Elmer Company Information
        10.7.2 Perkin Elmer Description and Business Overview
        10.7.3 Perkin Elmer Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
        10.7.4 Perkin Elmer Clinical Mass Spectrometry Products Offered
        10.7.5 Perkin Elmer Recent Development

 11 Industry Chain and Sales Channels Analysis
    11.1 Clinical Mass Spectrometry Industry Chain Analysis
    11.2 Clinical Mass Spectrometry Key Raw Materials
        11.2.1 Key Raw Materials
        11.2.2 Raw Materials Key Suppliers
    11.3 Clinical Mass Spectrometry Production Mode & Process
    11.4 Clinical Mass Spectrometry Sales and Marketing
        11.4.1 Clinical Mass Spectrometry Sales Channels
        11.4.2 Clinical Mass Spectrometry Distributors
    11.5 Clinical Mass Spectrometry Customers

 12 Research Findings and Conclusion

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

List of Tables
 Table 1. Clinical Mass Spectrometry CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030
 Table 2. Clinical Mass Spectrometry Market Trends
 Table 3. Clinical Mass Spectrometry Market Drivers
 Table 4. Clinical Mass Spectrometry Market Challenges
 Table 5. Clinical Mass Spectrometry Market Restraints
 Table 6. Global Clinical Mass Spectrometry Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. United States Clinical Mass Spectrometry Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global Clinical Mass Spectrometry Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. United States Clinical Mass Spectrometry Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 10. Global Key Manufacturers of Clinical Mass Spectrometry, Ranked by Revenue (2023) & (US$ Million)
 Table 11. Global Clinical Mass Spectrometry Revenue by Manufacturer, (US$ Million) & (2019-2024)
 Table 12. Global Clinical Mass Spectrometry Revenue Share by Manufacturer, 2019-2024
 Table 13. Global Clinical Mass Spectrometry Sales by Manufacturer, (K Units), 2019-2024
 Table 14. Global Clinical Mass Spectrometry Sales Share by Manufacturer, 2019-2024
 Table 15. Global Clinical Mass Spectrometry Price by Manufacturer (2019-2024) & (USD/Unit)
 Table 16. Global Clinical Mass Spectrometry Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 17. Global Clinical Mass Spectrometry by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Mass Spectrometry as of 2023)
 Table 18. Global Key Manufacturers of Clinical Mass Spectrometry, Manufacturing Base Distribution and Headquarters
 Table 19. Global Key Manufacturers of Clinical Mass Spectrometry, Product Offered and Application
 Table 20. Global Key Manufacturers of Clinical Mass Spectrometry, Date of Enter into This Industry
 Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 22. Key Players of Clinical Mass Spectrometry in United States, Ranked by Revenue (2023) & (US$ million)
 Table 23. United States Clinical Mass Spectrometry Revenue by Players, (US$ Million) & (2019-2024)
 Table 24. United States Clinical Mass Spectrometry Revenue Share by Players, (2019-2024)
 Table 25. United States Clinical Mass Spectrometry Sales by Players, (K Units) & (2019-2024)
 Table 26. United States Clinical Mass Spectrometry Sales Share by Players, (2019-2024)
 Table 27. Global Clinical Mass Spectrometry Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 28. Global Clinical Mass Spectrometry Sales in Volume by Region (2019-2024) & (K Units)
 Table 29. Global Clinical Mass Spectrometry Sales in Volume Forecast by Region (2025-2030) & (K Units)
 Table 30. Global Clinical Mass Spectrometry Sales in Value by Region (2019-2024) & (US$ Million)
 Table 31. Global Clinical Mass Spectrometry Sales in Value Forecast by Region (2025-2030) & (US$ Million)
 Table 32. Americas Clinical Mass Spectrometry Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. Americas Clinical Mass Spectrometry Sales in Value by Country (2019-2024) & (US$ Million)
 Table 34. Americas Clinical Mass Spectrometry Sales in Value by Country (2025-2030) & (US$ Million)
 Table 35. Americas Clinical Mass Spectrometry Sales in Volume by Country (2019-2024) & (K Units)
 Table 36. Americas Clinical Mass Spectrometry Sales in Volume by Country (2025-2030) & (K Units)
 Table 37. EMEA Clinical Mass Spectrometry Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. EMEA Clinical Mass Spectrometry Sales in Value by Country (2019-2024) & (US$ Million)
 Table 39. EMEA Clinical Mass Spectrometry Sales in Value by Country (2025-2030) & (US$ Million)
 Table 40. EMEA Clinical Mass Spectrometry Sales in Volume by Country (2019-2024) & (K Units)
 Table 41. EMEA Clinical Mass Spectrometry Sales in Volume by Country (2025-2030) & (K Units)
 Table 42. APAC Clinical Mass Spectrometry Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. APAC Clinical Mass Spectrometry Sales in Value by Country (2019-2024) & (US$ Million)
 Table 44. APAC Clinical Mass Spectrometry Sales in Value by Country (2025-2030) & (US$ Million)
 Table 45. APAC Clinical Mass Spectrometry Sales in Volume by Country (2019-2024) & (K Units)
 Table 46. APAC Clinical Mass Spectrometry Sales in Volume by Country (2025-2030) & (K Units)
 Table 47. Danaher Company Information
 Table 48. Danaher Description and Business Overview
 Table 49. Danaher Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 50. Danaher Clinical Mass Spectrometry Product
 Table 51. Danaher Recent Development
 Table 52. Bruker Company Information
 Table 53. Bruker Description and Business Overview
 Table 54. Bruker Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 55. Bruker Clinical Mass Spectrometry Product
 Table 56. Bruker Recent Development
 Table 57. Agilent Company Information
 Table 58. Agilent Description and Business Overview
 Table 59. Agilent Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 60. Agilent Clinical Mass Spectrometry Product
 Table 61. Agilent Recent Development
 Table 62. Thermo Fisher Company Information
 Table 63. Thermo Fisher Description and Business Overview
 Table 64. Thermo Fisher Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 65. Thermo Fisher Clinical Mass Spectrometry Product
 Table 66. Thermo Fisher Recent Development
 Table 67. Waters Company Information
 Table 68. Waters Description and Business Overview
 Table 69. Waters Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 70. Waters Clinical Mass Spectrometry Product
 Table 71. Waters Recent Development
 Table 72. Shidmazu Company Information
 Table 73. Shidmazu Description and Business Overview
 Table 74. Shidmazu Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 75. Shidmazu Clinical Mass Spectrometry Product
 Table 76. Shidmazu Recent Development
 Table 77. Perkin Elmer Company Information
 Table 78. Perkin Elmer Description and Business Overview
 Table 79. Perkin Elmer Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 80. Perkin Elmer Clinical Mass Spectrometry Product
 Table 81. Perkin Elmer Recent Development
 Table 82. Key Raw Materials Lists
 Table 83. Raw Materials Key Suppliers Lists
 Table 84. Clinical Mass Spectrometry Distributors List
 Table 85. Clinical Mass Spectrometry Customers List
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources


List of Figures
 Figure 1. Clinical Mass Spectrometry Product Picture
 Figure 2. Global Clinical Mass Spectrometry Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 3. Global Clinical Mass Spectrometry Market Size 2019-2030 (US$ Million)
 Figure 4. Global Clinical Mass Spectrometry Sales 2019-2030 (K Units)
 Figure 5. United States Clinical Mass Spectrometry Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 6. United States Clinical Mass Spectrometry Market Size 2019-2030 (US$ Million)
 Figure 7. United States Clinical Mass Spectrometry Sales 2019-2030 (K Units)
 Figure 8. United States Clinical Mass Spectrometry Market Share in Global, in Value (US$ Million) 2019-2030
 Figure 9. United States Clinical Mass Spectrometry Market Share in Global, in Volume (K Units) 2019-2030
 Figure 10. Clinical Mass Spectrometry Report Years Considered
 Figure 11. Product Picture of LC-MS
 Figure 12. Product Picture of MALDI-TOF MS
 Figure 13. Product Picture of Other
 Figure 14. Global Clinical Mass Spectrometry Market Share by Type in 2023 & 2030
 Figure 15. Global Clinical Mass Spectrometry Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 16. Global Clinical Mass Spectrometry Sales Market Share in Value by Type (2019-2030)
 Figure 17. Global Clinical Mass Spectrometry Sales by Type (2019-2030) & (K Units)
 Figure 18. Global Clinical Mass Spectrometry Sales Market Share in Volume by Type (2019-2030)
 Figure 19. Global Clinical Mass Spectrometry Price by Type (2019-2030) & (USD/Unit)
 Figure 20. United States Clinical Mass Spectrometry Market Share by Type in 2023 & 2030
 Figure 21. United States Clinical Mass Spectrometry Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 22. United States Clinical Mass Spectrometry Sales Market Share in Value by Type (2019-2030)
 Figure 23. United States Clinical Mass Spectrometry Sales by Type (2019-2030) & (K Units)
 Figure 24. United States Clinical Mass Spectrometry Sales Market Share in Volume by Type (2019-2030)
 Figure 25. United States Clinical Mass Spectrometry Price by Type (2019-2030) & (USD/Unit)
 Figure 26. Product Picture of Clinical Diagnostics
 Figure 27. Product Picture of Clinical Research
 Figure 28. Global Clinical Mass Spectrometry Market Share by Application in 2023 & 2030
 Figure 29. Global Clinical Mass Spectrometry Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 30. Global Clinical Mass Spectrometry Sales Market Share in Value by Application (2019-2030)
 Figure 31. Global Clinical Mass Spectrometry Sales by Application (2019-2030) & (K Units)
 Figure 32. Global Clinical Mass Spectrometry Sales Market Share in Volume by Application (2019-2030)
 Figure 33. Global Clinical Mass Spectrometry Price by Application (2019-2030) & (USD/Unit)
 Figure 34. United States Clinical Mass Spectrometry Market Share by Application in 2023 & 2030
 Figure 35. United States Clinical Mass Spectrometry Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 36. United States Clinical Mass Spectrometry Sales Market Share in Value by Application (2019-2030)
 Figure 37. United States Clinical Mass Spectrometry Sales by Application (2019-2030) & (K Units)
 Figure 38. United States Clinical Mass Spectrometry Sales Market Share in Volume by Application (2019-2030)
 Figure 39. United States Clinical Mass Spectrometry Price by Application (2019-2030) & (USD/Unit)
 Figure 40. The Top 5 and 10 Largest Manufacturers of Clinical Mass Spectrometry in the World: Market Share by Clinical Mass Spectrometry Revenue in 2023
 Figure 41. Global Clinical Mass Spectrometry Market Size Market Share by Region: 2019 VS 2023 VS 2030
 Figure 42. Global Clinical Mass Spectrometry Sales in Volume Market Share by Region (2019-2030)
 Figure 43. Global Clinical Mass Spectrometry Sales in Value Market Share by Region (2019-2030)
 Figure 44. Americas Clinical Mass Spectrometry Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 45. Americas Clinical Mass Spectrometry Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 46. Americas Clinical Mass Spectrometry Sales by Type (2019-2030) & (K Units)
 Figure 47. Americas Clinical Mass Spectrometry Sales Market Share in Volume by Type (2019-2030)
 Figure 48. Americas Clinical Mass Spectrometry Sales by Application (2019-2030) & (K Units)
 Figure 49. Americas Clinical Mass Spectrometry Sales Market Share in Volume by Application (2019-2030)
 Figure 50. United States Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Canada Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Mexico Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Brazil Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 54. EMEA Clinical Mass Spectrometry Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 55. EMEA Clinical Mass Spectrometry Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 56. EMEA Clinical Mass Spectrometry Sales by Type (2019-2030) & (K Units)
 Figure 57. EMEA Clinical Mass Spectrometry Sales Market Share in Volume by Type (2019-2030)
 Figure 58. EMEA Clinical Mass Spectrometry Sales by Application (2019-2030) & (K Units)
 Figure 59. EMEA Clinical Mass Spectrometry Sales Market Share in Volume by Application (2019-2030)
 Figure 60. Europe Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 61. Middle East Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 62. Africa Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 63. China Clinical Mass Spectrometry Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 64. China Clinical Mass Spectrometry Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 65. China Clinical Mass Spectrometry Sales by Type (2019-2030) & (K Units)
 Figure 66. China Clinical Mass Spectrometry Sales Market Share in Volume by Type (2019-2030)
 Figure 67. China Clinical Mass Spectrometry Sales by Application (2019-2030) & (K Units)
 Figure 68. China Clinical Mass Spectrometry Sales Market Share in Volume by Application (2019-2030)
 Figure 69. APAC Clinical Mass Spectrometry Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 70. APAC Clinical Mass Spectrometry Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 71. APAC Clinical Mass Spectrometry Sales by Type (2019-2030) & (K Units)
 Figure 72. APAC Clinical Mass Spectrometry Sales Market Share in Volume by Type (2019-2030)
 Figure 73. APAC Clinical Mass Spectrometry Sales by Application (2019-2030) & (K Units)
 Figure 74. APAC Clinical Mass Spectrometry Sales Market Share in Volume by Application (2019-2030)
 Figure 75. Japan Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 76. South Korea Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 77. China Taiwan Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 78. Southeast Asia Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 79. India Clinical Mass Spectrometry Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 80. Clinical Mass Spectrometry Value Chain
 Figure 81. Clinical Mass Spectrometry Production Process
 Figure 82. Channels of Distribution (Direct Vs Distribution)
 Figure 83. Bottom-up and Top-down Approaches for This Report
 Figure 84. Data Triangulation
 Figure 85. Key Executives Interviewed

Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics. Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.

The global Clinical Mass Spectrometry revenue was US$ 925 million in 2023 and is forecast to a readjusted size of US$ 1798 million by 2030 with a CAGR of 10.1% during the review period (2024-2030).

In United States the Clinical Mass Spectrometry revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Clinical Mass Spectrometry market, also covers the segmentation data of other regions in regional level and county level.

Market Segmentation

Industry: Medical Devices & Consumables

Published: 2024-10-09

Pages: 108 Pages

Report ld: 3337622

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 4350.00

Multi Users License

USD 6525.00